Bird & Bird advised Nexstim on cooperation and investment agreements with Brainlab

International law firm Bird & Bird has successfully advised Nexstim Plc, a Finnish, globally operating growth-oriented medical technology company, on its cooperation agreement and investment agreement with Brainlab AG, a leading German developer of advanced medical technology solutions.

The cooperation agreement aims at the advancement of non-invasive brain mapping technologies, as well as the distribution of certain Nexstim products by Brainlab in the segment. 

In connection with the cooperation agreement, Brainlab and Nexstim have also agreed on a maximum of EUR 5,095,000 equity investment into Nexstim by Brainlab. 

Bird & Bird’s advisory team, consisting of partners Maria Carlsson, Laura Huomo, and Iina-Mari Supperi, along with Counsel Vuokko Rajamäki and associates Juliana Kliesch, Marla Melin and Rondy Stenman, provided comprehensive legal support for both the cooperation and investment agreements.

News & Deals

More News & Deals
News Bird & Bird adds bench strength in Germany with two new partner hires

Dec 29 2025

Read More
Deal Bird & Bird advises the African Development Bank on €100 million financing to strengthen the cocoa sector in Ivory Coast

Dec 18 2025

Read More
Deal Bird & Bird advises ASX-listed Flight Centre Travel Group on its acquisition of Iglu

Dec 17 2025

Read More
Deal Bird & Bird advises Pathos Communications plc on its AIM IPO

Dec 17 2025

Read More
Deal Bird & Bird advises Orphalan on the acquisition of Orphelia Pharma

Dec 16 2025

Read More
Deal Bird & Bird ATMD advises SuperX on Strategic Investment in NVIDIA Solution Provider MicroInference

Dec 15 2025

Read More